Igor Tsigelny

Co-Founder & Advisor at CureMatch

Igor originally developed the CureMatch technology while serving as a Research Professor at the Department of Neurosciences, San Diego Supercomputer Center, and Moore’s Cancer Center (MCC). He is a member of the Molecular Tumor Board of the MCC and is a recognized expert in molecular mechanisms of disease, structural biology, molecular modeling, bioinformatics, and structure-based drug design.

Dr. Tsigelny has authored over 200 papers in peer-reviewed journals including Nature, Science, and Proceedings of the National Academy of Sciences. He has designed three drug candidates—aimed at Parkinson’s disease, brain cancer, and hypertension—which have all been licensed by UCSD to pharmaceutical companies and are in various stages of development.

Links

Timeline

  • Co-Founder & Advisor

    Current role

  • Chief Science Officer & Co-founder